kentucky glp-1 vomiting legal team law office The Law Offices of Timothy L. Miles semaglutide digestive blockage law office

Note what happened and continue your regular schedule

Known Risks of GLP-1 Use While Nursing The primary concern with GLP-1 therapy in breastfeeding mothers is not confirmed harm to infants but rather the lack of specific safety data in this population

GLP-1 receptor agonists, including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound), are increasingly prescribed for type 2 diabetes and weight management

Hair loss has emerged as a concern in the GLP-1 community, though research suggests this is more related to rapid weight loss and caloric restriction than to the medication itself

Greater understanding of trial generalizability is needed. In the cross-sectional study, the researchers examined a cohort of 8,767 participants aged 20 years or older from the National Health and Nutrition Examination Survey to determine proportions of those who were met the FDAs label criteria for weight loss treatment and those who met trial exclusion criteria